VRNA logo

Verona Pharma (VRNA) Cash From Financing

Annual CFF

$250.78 M
+$157.91 M+170.04%

December 31, 2024


Summary


Performance

VRNA Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherVRNAcash flowmetrics:

Quarterly CFF

$94.16 M
+$101.24 M+1428.59%

December 31, 2024


Summary


Performance

VRNA Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherVRNAcash flowmetrics:

TTM CFF

$250.78 M
+$70.14 M+38.83%

December 31, 2024


Summary


Performance

VRNA TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherVRNAcash flowmetrics:

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

VRNA Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+170.0%+292.1%+170.0%
3 y3 years+4199.7%+292.1%+170.0%
5 y5 years+100.0%+292.1%+170.0%

VRNA Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+4199.7%-43.6%+1428.6%at high+3764.8%
5 y5-yearat high+4199.7%-50.0%+1428.6%at high+3764.8%
alltimeall timeat high+4199.7%-50.0%+1428.6%at high+3764.8%

Verona Pharma Cash From Financing History

DateAnnualQuarterlyTTM
Dec 2024
$250.78 M(+170.0%)
$94.16 M(-1428.6%)
$250.78 M(+38.8%)
Sep 2024
-
-$7.09 M(-104.2%)
$180.63 M(-3.8%)
Jun 2024
-
$166.83 M(-5442.0%)
$187.77 M(+791.5%)
Mar 2024
-
-$3.12 M(-113.0%)
$21.06 M(-77.3%)
Dec 2023
$92.87 M(-34.1%)
$24.01 M(>+9900.0%)
$92.87 M(+29.9%)
Sep 2023
-
$48.00 K(-61.3%)
$71.47 M(-66.1%)
Jun 2023
-
$124.00 K(-99.8%)
$211.04 M(+0.4%)
Mar 2023
-
$68.69 M(+2527.6%)
$210.23 M(+49.3%)
Dec 2022
$140.82 M(-2402.1%)
$2.61 M(-98.1%)
$140.82 M(+2.6%)
Sep 2022
-
$139.62 M(<-9900.0%)
$137.30 M(-3422.1%)
Jun 2022
-
-$689.00 K(-5.1%)
-$4.13 M(-39.6%)
Mar 2022
-
-$726.00 K(-19.4%)
-$6.84 M(+11.9%)
Dec 2021
-$6.12 M(-103.2%)
-$901.00 K(-50.4%)
-$6.12 M(+383.2%)
Sep 2021
-
-$1.82 M(-46.5%)
-$1.27 M(-100.7%)
Jun 2021
-
-$3.40 M(<-9900.0%)
$188.94 M(-1.8%)
Mar 2021
-
$0.00(-100.0%)
$192.34 M(0.0%)
Dec 2020
$192.34 M(>+9900.0%)
$3.95 M(-97.9%)
$192.34 M(+1.9%)
Sep 2020
-
$188.39 M(>+9900.0%)
$188.76 M(>+9900.0%)
Jun 2020
-
$0.00(0.0%)
$212.90 K(+94.3%)
Mar 2020
-
$0.00(-100.0%)
$109.60 K(>+9900.0%)
Dec 2019
$0.00
$372.00 K(-333.8%)
$0.00(-100.0%)
DateAnnualQuarterlyTTM
Sep 2019
-
-$159.10 K(+54.0%)
-$372.00 K(+74.7%)
Jun 2019
-
-$103.30 K(-5.7%)
-$212.90 K(+94.3%)
Mar 2019
-
-$109.60 K(<-9900.0%)
-$109.60 K(<-9900.0%)
Dec 2018
$0.00(-100.0%)
$0.00(0.0%)
$0.00(-100.0%)
Sep 2018
-
$0.00(0.0%)
$742.00 K(-73.7%)
Jun 2018
-
$0.00(0.0%)
$2.82 M(-96.8%)
Mar 2018
-
$0.00(-100.0%)
$86.79 M(+1.5%)
Dec 2017
$85.47 M(+68.1%)
$742.00 K(-64.3%)
$85.47 M(+0.9%)
Sep 2017
-
$2.08 M(-97.5%)
$84.73 M(+2.5%)
Jun 2017
-
$83.97 M(-6455.3%)
$82.65 M(-6355.3%)
Mar 2017
-
-$1.32 M
-$1.32 M
Dec 2016
$50.84 M(>+9900.0%)
-
-
Dec 2015
$0.00(-100.0%)
-
-
Dec 2014
$20.39 M(+586.2%)
-
-
Dec 2013
$2.97 M(+81.3%)
-
-
Dec 2012
$1.64 M(-50.2%)
-
-
Dec 2011
$3.29 M(+144.2%)
-
-
Dec 2010
$1.35 M(-58.5%)
-
-
Dec 2009
$3.25 M(-8.9%)
-
-
Dec 2008
$3.57 M(+6.6%)
-
-
Dec 2006
$3.35 M(+104.2%)
-
-
Dec 2005
$1.64 M
-
-

FAQ

  • What is Verona Pharma annual cash flow from financing activities?
  • What is the all time high annual CFF for Verona Pharma?
  • What is Verona Pharma annual CFF year-on-year change?
  • What is Verona Pharma quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Verona Pharma?
  • What is Verona Pharma quarterly CFF year-on-year change?
  • What is Verona Pharma TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Verona Pharma?
  • What is Verona Pharma TTM CFF year-on-year change?

What is Verona Pharma annual cash flow from financing activities?

The current annual CFF of VRNA is $250.78 M

What is the all time high annual CFF for Verona Pharma?

Verona Pharma all-time high annual cash flow from financing activities is $250.78 M

What is Verona Pharma annual CFF year-on-year change?

Over the past year, VRNA annual cash flow from financing activities has changed by +$157.91 M (+170.04%)

What is Verona Pharma quarterly cash flow from financing activities?

The current quarterly CFF of VRNA is $94.16 M

What is the all time high quarterly CFF for Verona Pharma?

Verona Pharma all-time high quarterly cash flow from financing activities is $188.39 M

What is Verona Pharma quarterly CFF year-on-year change?

Over the past year, VRNA quarterly cash flow from financing activities has changed by +$70.14 M (+292.12%)

What is Verona Pharma TTM cash flow from financing activities?

The current TTM CFF of VRNA is $250.78 M

What is the all time high TTM CFF for Verona Pharma?

Verona Pharma all-time high TTM cash flow from financing activities is $250.78 M

What is Verona Pharma TTM CFF year-on-year change?

Over the past year, VRNA TTM cash flow from financing activities has changed by +$157.91 M (+170.04%)